High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose

Annals of Pharmacotherapy

Volumn 34, Issue 10, 2000, Pages 1146-1151

  Kane, S L ^a   Constantiner, M ^a   Staubus, A E ^a   Meinecke, C D ^a   Sedor, J R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Hemodialysis; Overdose; Thrombocytopenia; Valproic acid

Indexed keywords

CHARCOAL; DOXEPIN; LACTIC ACID; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEVICE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG OVERDOSE; FEMALE; HEMODIALYSIS; HEMOPERFUSION; HUMAN; HYPOTENSION; LACTIC ACIDOSIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 0033774738     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19387     Document Type: Article

References (24)

1. Blood dyscrasias with carbamezapine and valproate: A pharmacoepidemiologic study of 2,228 patients at risk
2. Sodium valproate, platelet dysfunction and bleeding
3. Sodium valproate and bone marrow suppression
4. Successful treatment of valproic acid overdose with hemodialysis
5. Simultaneous 'in series' hemodialysis and hemoperfusion in the management of valproic acid overdose
6. Cerebral edema following acute sodium valproate overdose
7. Multiorgan system failure caused by valproic acid toxicity
8. Hepatotoxicity to sodium valproate: A review
9. 1998 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
10. The effect of repeated-dose activated charcoal in the pharmacokinetics of sodium valproate in healthy volunteers
11. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy
12. Delayed peak serum valproic acid in massive divalproate overdose - Treatment with charcoal hemoperfusion
13. Acute valproic acid intoxication. Enhanced drug clearance with oral-activated charcoal
14. Sodium valproate poisoning
15. The effect of hemodialysis and hemoperfusion on serum valproic acid concentration
16. Pharmacokinetics and bioavailability of sodium valproate
17. A method for estimating the probability of adverse drug reactions
18. Valproate plasma protein binding in the uremic condition
19. Hemodialysis of valproic acid in uremic patients
20. Extracorporeal techniques in the treatment of poisoned patients
21. Influence of renal function and dialysis on drug disposition
22. Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis
23. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder
24. Thrombocytopenia associated with sodium valproate treatment